Latest News

Cencora (NYSE:COR) has signed a binding agreement to acquire the retina division of EyeSouth Partners, expanding its Retina Consultants of America network. The transaction centers on advanced retina care services and is intended to deepen Cencora's presence in ophthalmology-focused healthcare offerings. The company also announced the planned retirement of Chief Financial Officer James F. Cleary and has initiated an executive search for his successor. Cencora operates across pharmaceutical...

In late March 2026, activist short seller Morpheus Research released a report alleging that MakeMyTrip violated regulatory bans on price parity clauses and raised questions about accounting practices, including the treatment of a receivable from insolvent airline Go Air. The report also highlighted a large gap between MakeMyTrip’s adjusted profits and IFRS figures, bringing renewed attention to the company’s financial transparency and regulatory exposure. We’ll now explore how these...

KalVista Pharmaceuticals recently reported new interim results from its KONFIDENT-KID trial, showing that EKTERLY (sebetralstat) oral disintegrating tablets treated 172 hereditary angioedema attacks in 33 children aged 2–11 with rapid symptom relief and no serious or treatment-related adverse events. The data highlight how an easy-to-administer oral option could address a major gap in pediatric hereditary angioedema care, where current on-demand treatment for young patients in the US is...

Analyst downgrades and CEO exit put Adobe’s risk profile in focus Recent downgrades of Adobe (ADBE) and the planned retirement of long-serving CEO Shantanu Narayen have put leadership, pricing power, and AI competition at the center of the stock’s story for investors. Several research houses, including William Blair, have questioned how resilient Adobe’s Creative Cloud economics are as free or low cost design tools and AI native rivals gain traction, even as the company continues to invest...

Wondering whether Reply is starting to look attractively priced after a tough run, or if the current share price still leaves questions on value. Reply shares last closed at €82.05, after a recent 5% gain over 7 days but still showing a 9.1% decline over 30 days and a 26.0% decline year to date, with a 44.0% decline over the past year. These moves have put valuation and risk firmly in focus for investors, especially as longer term performance over 3 and 5 years, at 24.5% and 22.8% declines...

CME Group (NasdaqGS:CME) reports record trading volumes across all product categories. The company launches 24/7 trading for regulated cryptocurrency futures and options. CME partners with BMO and Google Cloud to roll out 24/7 tokenized cash settlement for institutional clients. CME Group, trading at $305.11, is drawing attention after reporting all time record volumes across multiple asset classes and pushing further into round the clock trading. The stock is up 13.1% year to date and...

SmartCentres Real Estate Investment Trust finalized new five year arrangements with Penguin Group, reinforcing its core operating partnership. The Executive Chairman and CEO has agreed to extend his leadership of SmartCentres through December 2030. An independent committee of trustees unanimously recommended the agreements, which have now been approved. For investors watching TSX:SRU.UN, this governance update adds fresh context to a unit price that most recently closed at CA$27.41. The...

Millicom International Cellular: Recent Performance Snapshot Millicom International Cellular (TIGO) has caught investor attention after a strong run, with the stock showing gains over the past week, month and past 3 months that outpace its recent daily move. With a recent close of $79.64 and a market value of about $12.88b, investors are weighing this price action against Millicom’s reported $5,819.0 in revenue, $1,316.0 in net income and a value score of 5. See our latest analysis for...

Fermi Inc., in partnership with the Texas Tech University System, recently arranged up to US$156.25 million in unsecured debt financing alongside a US$165.00 million equipment loan, while advancing permitting and regulatory filings for its large-scale Project Matador energy campus in Texas. These moves, paired with a US$486.38 million net loss in 2025 and plans for up to ~17 GW of generation including nuclear, gas, solar, and batteries, highlight Fermi’s push to build a privately funded...

Eli Lilly (LLY) has surged back into the spotlight after the FDA approved Foundayo, a once daily oral GLP 1 pill for obesity that expands the company’s weight loss portfolio beyond injectables. See our latest analysis for Eli Lilly. The FDA approval of Foundayo comes after an already active period for Eli Lilly, with recent acquisitions in neuroscience and new data across dermatology and psoriatic arthritis. Over the same time, the share price has seen a 30 day return of 7.16% and a 90 day...

If you are wondering whether Pool's current share price lines up with its underlying value, this article walks through the numbers so you can judge that for yourself. Pool last closed at US$202.93, with returns of 0.9% over 7 days, an 8.3% decline over 30 days, an 11.7% decline year to date and a 34.1% decline over 1 year that many investors are watching closely. Over the past few months, coverage of Pool has focused on how the share price performance compares with broader retail...

Escalating geopolitical tensions are driving fresh attention to Elbit Systems' role in drone and electronic warfare. Recent material updates highlight stronger global demand for advanced unmanned systems and electronic warfare platforms. Elbit Systems, TASE:ESLT, is being cited as a key supplier as militaries reassess modernization priorities. Elbit Systems, TASE:ESLT, operates across unmanned aerial systems, electronic warfare equipment, and broader defense technologies. Recent...

Multiple law firms and investor groups have launched class action lawsuits against Nektar Therapeutics (NasdaqCM:NKTR). The suits allege securities fraud tied to protocol violations in the Phase 2b REZOLVE-AA trial. Claims focus on whether Nektar misled investors about enrollment and data integrity for this alopecia areata study. These legal actions introduce new uncertainty around the company’s clinical programs and governance practices. Nektar Therapeutics focuses on developing drug...

Comcast Xfinity is in a carriage dispute with E.W. Scripps that has triggered immediate blackouts of major broadcast networks and key sports programming in several U.S. markets. At the same time, Comcast has entered a partnership with NVIDIA to deploy real-time AI applications at the network edge across parts of its infrastructure. Both developments are material for NasdaqGS:CMCSA investors because they touch core video services, customer experience, and future network...

In late March 2026, On Holding AG announced a leadership shake-up effective May 1, 2026, with co-founders David Allemann and Caspar Coppetti becoming Co-CEOs, long-time CEO and former CFO Martin Hoffmann stepping down into an advisory role, and Frank Sluis joining as the new CFO. The reorganization places the founders directly in charge of day-to-day execution while elevating President & COO Scott Maguire to oversee the entire value chain, potentially tightening the link between product...

In March 2026, NGK Insulators, Ltd. raised its year-end dividend forecast for the fiscal year ending March 31, 2026 to ¥42 per share, lifting the expected annual dividend to ¥80 per share, citing steady performance in its Environment and Digital Society businesses. This dividend revision underlines management’s emphasis on shareholder returns, including a medium-term goal of a 3% dividend on equity ratio and a consolidated payout ratio around 30%. Next, we’ll examine how NGK’s higher...

Why Asahi Kasei (TSE:3407) is on investor radars today Asahi Kasei (TSE:3407) has attracted attention after recent share price moves, with the stock last closing at ¥1,560 and showing mixed returns over the past month and past 3 months. See our latest analysis for Asahi Kasei. Recent moves fit into a broader picture where the 90 day share price return of 12.31% and year to date gain of 9.86% contrast with a 1 year total shareholder return of 64.23%, suggesting earlier momentum is cooling. If...

Why SEI Investments Is On Investors’ Radar Recent share performance has put SEI Investments (SEIC) back in focus for investors, with the stock showing a 7.2% decline over the past 3 months and a 6.8% decline over the past month. See our latest analysis for SEI Investments. The recent 1 day share price return of a 1.32% decline and a year to date share price return of a 7.23% decline contrast with a 1 year total shareholder return of 6.04%. This suggests that shorter term momentum has faded...

Alamos Gold (TSX:AGI) has moved back into focus after upgrades from major institutions such as Bank of America and Stifel, with recent price action highlighting stronger technical signals alongside renewed interest in gold. See our latest analysis for Alamos Gold. These upgrades and recent technical strength sit against a mixed short term picture, with a 7 day share price return of 14.65% and a 30 day share price return of 10.36%. Over the longer term, total shareholder returns, including...

On March 31, 2026, Lumine Group Senior Officer David Sharpley purchased 5,000 Subordinate Voting Shares at US$22.502 each, increasing his direct holdings by 14.9%. This insider purchase highlights a meaningful personal capital commitment from a key executive, which many investors watch as a signal of internal confidence. We’ll now explore how this insider buying by a senior officer shapes Lumine Group’s broader investment narrative and perceived management conviction. Outshine the giants:...

In late March 2026, FactSet Research Systems reported Q2 results showing higher sales than a year earlier, raised its full-year 2026 revenue and earnings guidance, continued buying back shares under its existing repurchase program, and advanced multiple AI initiatives including AI-enabled Document Search and the alpha launch of FactSet AI for Banking with Finster AI. These developments highlight FactSet’s effort to reposition itself as an AI-enabled data and workflow infrastructure provider,...

Mitsubishi Motors North America reported that first-quarter 2026 sales fell 15% year over year to 26,884 units, largely due to the sell-through of the Mirage subcompact, while its SUV lineup achieved more than 10% growth in the same period. Later in 2026, the company plans to launch its first battery-electric vehicle and an off-road-focused Outlander variant, signaling a shift toward higher-value models and electrification within its Momentum 2030 plan. We’ll now examine how Mitsubishi’s...

Rambus (RMBS) has come under pressure after two executives sold a combined US$4.6 million in stock in early March, a concentrated bout of insider selling that has unsettled some investors. See our latest analysis for Rambus. Despite the recent insider sales and sector weakness that pushed the share price lower in recent months, Rambus now trades at US$93.03, with a 6.21% 1 month share price return but a 6.30% share price decline year to date, set against a very large 101.58% 1 year total...

Citi recently raised its outlook on Cheniere Energy, highlighting how ongoing geopolitical disruption in the Middle East has reinforced long-term demand for secure U.S. LNG supplies, supported by the company’s expanding capacity and high contracted volumes through 2030. A key insight is that Cheniere is converting these geopolitical tailwinds into contracted cash flows, underlined by new long-dated deals such as its supply agreement with CPC Corporation of Taiwan running through 2050 and a...